Article
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.
Nature genetics - 1 Jun 2007
Steinthorsdottir Valgerdur, Thorleifsson Gudmar, Reynisdottir Inga, Benediktsson Rafn, Jonsdottir Thorbjorg, Walters G Bragi, Styrkarsdottir Unnur, Gretarsdottir Solveig, Emilsson Valur, Ghosh Shyamali, Baker Adam, Snorradottir Steinunn, Bjarnason Hjordis, Ng Maggie C Y, Hansen Torben, Bagger Yu, Wilensky Robert L, Reilly Muredach P, Adeyemo Adebowale, Chen Yuanxiu, Zhou Jie, Gudnason Vilmundur, Chen Guanjie, Huang Hanxia, Lashley Kerrie, Doumatey Ayo, So Wing-Yee, Ma Ronald C Y, Andersen Gitte, Borch-Johnsen Knut, Jorgensen Torben, van Vliet-Ostaptchouk Jana V, Hofker Marten H, Wijmenga Cisca, Christiansen Claus, Rader Daniel J, Rotimi Charles, Gurney Mark, Chan Juliana C N, Pedersen Oluf, Sigurdsson Gunnar, Gulcher Jeffrey R, Thorsteinsdottir Unnur, Kong Augustine, Stefansson Kari
Abstract excerpt
We conducted a genome-wide association study for type 2 diabetes (T2D) in Icelandic cases and controls, and we found that a previously described variant in the transcription factor 7-like 2 gene (TCF7L2) gene conferred the most significant risk. In addition to confirming two recently identified r...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
